Journal of Internal Medicine Concepts & Practice >
Guidelines for clinical management of novel coronavirus infection in pituitary disease
Chinese Society of Endocrinology . Guidelines for clinical management of novel coronavirus infection in pituitary disease[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(01) : 18 -21 . DOI: 10.16138/j.1673-6087.2023.01.006
[1] | Yuen KCJ, Blevins LS Jr, Findling JW. Important ma-nagement considerations in patients with pituitary disorders during the time of the Covid-19 pandemic[J]. Endocr Pract, 2020, 26(8): 915-922. |
[2] | Fleseriu M, Dekkers OM, Karavitaki N. Endocrinology in the time of COVID-19: management of pituitary tumours[J]. Eur J Endocrinol, 2020, 183(1): G17-G23. |
[3] | Fleseriu M, Buchfelder M, Cetas JS, et al. Pituitary Society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective[J]. Pituitary, 2020, 23(4): 327-337. |
[4] | Christ-Crain M, Hoorn EJ, Sherlock M, et al. Endocrinology in the time of COVID-19: management of diabetes insipidus and hyponatraemia[J]. Eur J Endocrinol, 2020, 183(1): G9-G15. |
[5] | Christ-Crain M, Hoorn EJ, Sherlock M, et al. Endocrinology in the time of COVID-19-2021 updates: the management of diabetes insipidus and hyponatraemia[J]. Eur J Endocrinol, 2021, 185(4): G35-G42. |
[6] | 中华医学会内分泌学分会. 肢端肥大症诊治中国专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36(9): 751-760. |
[7] | 中国垂体腺瘤协作组. 中国肢端肥大症诊治共识(2021版)[J]. 中华医学杂志, 2021, 101(27): 2115-2126. |
[8] | 中国垂体腺瘤协作组. 中国库欣病诊治专家共识(2015)[J]. 中华医学杂志, 2016, 96(11): 835-840. |
[9] | Isidori AM, Arnaldi G, Boscaro M, et al. COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency[J]. J Endocrinol Invest, 2020, 43(8): 1141-1147. |
[10] | Arlt W, Baldeweg SE, Pearce SHS, et al. Endocrinology in the time of COVID-19: management of adrenal insufficiency[J]. Eur J Endocrinol, 2020, 183(1): G25-G32. |
[11] | Pal R, Joshi A, Bhadada SK, et al. Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence[J]. Endocr Pract, 2022, 28(4): 425-432. |
[12] | 中华医学会内分泌学分会肥胖学组. 肾上腺皮质功能减退症患者围手术期糖皮质激素管理专家共识[J]. 中华内分泌代谢杂志, 2022, 38(1): 1-6. |
[13] | Clarke SA, Abbara A, Dhillo WS. Impact of COVID-19 on the endocrine system: a mini-review[J]. Endocrinology, 2022, 163(1):bqab203. |
[14] | Tan T, Khoo B, Mills EG, et al. Association between high serum total cortisol concentrations and mortality from COVID-19[J]. Lancet Diabetes Endocrinol, 2020, 8(8): 659-660. |
[15] | Tan T, Khoo B, Mills EG, et al. Cortisol concentrations and mortality from COVID-19 - authors’ reply[J]. Lancet Diabetes Endocrinol, 2020, 8(10):809-810. |
[16] | Pivonello R, Ferrigno R, Isidori AM, et al. COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess[J]. Lancet Diabetes Endocrinol, 2020, 8(8): 654-656. |
[17] | Newell-Price J, Nieman LK, Reincke M, et al. Endocrinology in the time of COVID-19: management of Cushing’s syndrome[J]. Eur J Endocrinol, 2020, 183(1): G1-G7. |
[18] | 王卫庆, 单忠艳, 王广, 等. 新型冠状病毒肺炎疫情期间糖尿病基层管理专家建议[J]. 中华内分泌代谢杂志, 2020, 36(3): 185-190. |
[19] | 中国医师协会内分泌代谢科医师分会, 中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1): 1-10. |
[20] | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. |
/
〈 |
|
〉 |